An interventional study of Sleep recording in Sleep Disorder (Disorder), sponsored by University Hospital, Toulouse. Recruiting at 1 site in France. Open to participants aged 18 Years to 65 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-04-08.
Sponsored by University Hospital, Toulouse · Not applicable, Interventional, and Prevention
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 65 studies in Sleep Wake Disorders with a site in France — 22 open to participants now, 27 under way, 4 of them phase 3. Sleep Wake Disorders · France.
Among the 65 studies in Sleep Wake Disorders with a site in France, this one is the 36th largest by planned enrollment of the 42 interventional ones that give a count, is one of 9 that started in 2026, is one of 29 with no phase, reaches primary completion later than 15 of the 26 other live ones, and was the 57th registered.
747 studies on the registry are indexed under Sleep Wake Disorders; 181 are open to participants now.
Browse Sleep Wake Disorders studies →22 of the 65 studies in Sleep Wake Disorders with a site in France are open now. Recruiting first, the newest first:
Replior AB · Sites in France
Ages 18–65
Direction Centrale du Service de Santé des Armées · Sites in France
Ages 18–65
Alkermes, Inc. · Sites in France, United States, Australia and 11 more countries
Ages 18–70
Alkermes, Inc. · Sites in France, United States, Australia and 12 more countries
Ages 18–70
French Cardiology Society · Sites in France
Ages 18+
A study can be open while its sites in France have not opened yet or have stopped. Only those recruiting at a site in France →
Of the 114 Sleep Wake Disorders studies recruiting now, 40 (35%) set no upper age limit and 53 (46%) stop at 75 or younger; 22 take children under 18; 28 take healthy volunteers.
This study: 18 Years to 65 Years · all sexes · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
65 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 2 6 · Phase 3 6 · Phase 4 2
First in 2009; this study’s year is marked. 9 started in 2026.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 32 is below the median of 66 across 531 interventional studies indexed under Sleep Wake Disorders.
Median enrollment 87 across the 42 interventional studies, 100 across the 23 observational. Of the 31 that completed or were terminated, 2 (6%) have results posted.
This tab as a report to print or save as PDF → With an account.
12 of 65 have an industry lead sponsor. The 10 most frequent:
University Hospital, Toulouse is the lead sponsor of 809 studies on the registry; 211 are open to participants now.
University Hospital, Toulouse has 1 study filed under Sleep Wake Disorders — fewer than ten, so there is no comparison to draw.
14 of the studies in Sleep Wake Disorders with a site in France that are under way reach primary completion within a year, 2 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07502443Phase 3Alkermes, Inc.A Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 2 | 2027-05 |
| NCT07455383Phase 3Alkermes, Inc.A Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 1 | 2027-05 |
| NCT06843590Alkermes, Inc.A Study to Evaluate the Safety and Effectiveness of ALKS 2680 in Subjects With Idiopathic Hypersomnia | 2026-11 |
| NCT07628959Centre Hospitalier Universitaire de Saint EtienneInnovative Sleep Quality Analysis Software Compared With Polysomnography | 2026-12 |
| NCT07909967Replior ABObservational Analytical Validation Study of the Replior ScratchSense | 2026-12-10 |
Add all 14 to your calendar (.ics) → With an account.
Among the 65 studies in Sleep Wake Disorders with a site in France, from their registry updates:
This tab as a report to print or save as PDF → With an account.
Sleep organization and cardiorespiratory parameters are disrupted in extreme conditions such as high altitude. The pathophysiology of medical problems related to acute high-altitude exposure is partially understood, but sleep quality indicators are very rarely measured under these conditions. This lack of information is even more pronounced among employees subjected to cyclical exposure to high-altitude hypoxic stress, as is the case for the employees at the Pic du Midi. These 32 employees regularly report to their occupational physician difficulties in managing their sleep disorders, struggling to distinguish symptoms from objective changes in their sleep cycles. Among them, 13 are on call at the summit of the Pic du Midi (2,877 m), while 19 work there during the day and return home to a lower altitude at night to sleep. The investigators also wish to measure structural changes in sleep and its cardiorespiratory parameters using polysomnography in these 13 employees, comparing nights spent at home at normal altitude with those spent at the summit of the Pic du Midi. These changes will also be compared to those of a group of 19 employees who do not sleep at high altitude..
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Group "with on-call night at high altitude at the Pic du Midi":
Night group "without on-call night at high altitude":
Exclusion Criteria:
employees of the Pic du Midi who spend the night at high altitude
Other: Sleep recording
employees of the Pic du Midi who spend the night at home in the plain
Other: Sleep recording
Polysomnography and questionnaires.
Comparison of sleep efficiency (total sleep time / total sleep period) under high altitude conditions (at 2877 m) versus without increased altitude (at home)
Sleep efficiency will be compared, according to the ratio = total sleep time (TST)/ total sleep period (PTS) calculated from a polysomnographic recording, between the night spent at high altitude (2877m, at PIC du MIDI) and the second night spent at home (not increased altitude) among PIC du MIDI employees performing on-call nights at high altitude.
Time frame: 1 week after the inclusion
Comparison of sleep parameters in high altitude conditions versus without increased altitude for the group "with on-call night at high altitude at Pic du Midi"
Sleep parameters (determined according to the criteria of the American Academy of Sleep Medicine (AASM)) measured from a polysomnographic recording will be compared in high altitude conditions versus without increased altitude.
Time frame: 1 week after the inclusion
Measurement of sleep parameters in low altitude conditions for the group "without on-call nights at high altitude"
Sleep parameters (determined according to the criteria of the American Academy of Sleep Medicine (AASM)) will be measured from a polysomnographic recording under conditions without altitude gain.
Time frame: 1 week after the inclusion
Evaluation of the relationship between sleep quantification criteria and sleep disorder criteria
Comparison of questionnaire responses and polysomnographic recording
Time frame: 1 week after the inclusion
Correlation between cardiac parameters and sleep efficiency.
Correlation between heart rate variability and sleep efficiency using polysomnography recording
Time frame: 1 week after the inclusion
Comparison of sleep parameters, in conditions without increased altitude, between the 2 groups of participants
Comparison of sleep parameters (determined according to the criteria of the American Academy of Sleep Medicine (AASM)) from the polysomnography recording between the two groups in conditions without increased altitude
Time frame: 1 week after the inclusion
Plan to share: No
No publications or documents are linked to this record.
Started Mar 2026 (actual). Primary completion is estimated for Feb 2027, 10 months after the start.
Of 214 non-industry interventional studies with no phase under Sleep Wake Disorders, half reached primary completion within 21 months of starting (the median), counting those still running; a quarter within 7 and three quarters within 40. This study's planned 10 months is below that.
Counting every sponsor, half of 249 studies reached it within 19 months; a quarter within 6 and three quarters within 37.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University Hospital, Toulouse →